Venture Map · Round
DeepUll — Series B · €17M
Announced 2023-03-01 · Barcelona · Medtech / In-vitro diagnostics
Barcelona Science Park-based DeepUll, which develops culture-free molecular diagnostics for early sepsis detection, announced that Sabadell Asabys had entered its Series B through the new SAHII II fund, taking the round to €17 million in total. Roughly €13 million had been announced in October 2022, with Asabys adding about €4 million in this final close alongside Werfen and the existing syndicate.
RoundSeries B
Amount€17M
LeadNot disclosed
Date2023-03-01
CityBarcelona
SectorMedtech / In-vitro diagnostics
